A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Clinical trial NCT06385821 · COMPLETED

Trial details

NCT number: NCT06385821
Sponsor: NPO Petrovax
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza Influenza A Influenza, Human Influenza Type B Flu Influenza A H3N2 Influenza A H1N1 Influenza Epidemic Flu, Human Acute Respiratory Infection Vaccine Reaction

Start date: 2022-09-21
Primary completion: 2023-06-15
Enrollment: 824

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.